Table 2.
Adverse events
Ondansetron (n = 18) | Placebo (n = 18) | |
Constipation | 7 | 6 |
Required laxative | 3 | 1 |
Headache | 1 | 1 |
ALT (d0/d60) | 72.8 (58.0)/61.6 (56.3) | 64.5 (50.9)/68.0 (64.0) |
There were no significant changes in laboratory parameters during the study, and in particular no increases in liver enzymes (alanine aminotransferase (ALT)).